Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessment.
CONCLUSIONS: On the basis of the available evidence it is uncertain whether LPV/r and other antiretrovirals improve clinical outcomes or prevent infection among patients at high risk of acquiring COVID-19.
PMID: 32293807 [PubMed - as supplied by publisher]
Source: Journal of the International AIDS Society - Category: Infectious Diseases Tags: J Int AIDS Soc Source Type: research
More News: Clinical Trials | Coronavirus | COVID-19 | Databases & Libraries | HIV AIDS | Infectious Diseases | MERS | SARS | Statistics | Study